A hydrogel delivery system boosts single-dose efficacy and provides a potential tool to fight future pandemics and vaccine inequity.
![Hydrogel vaccines could spell the end of booster shots and vaccine inequity](https://www.advancedsciencenews.com/wp-content/uploads/2023/06/afif-ramdhasuma-lPjeFCIFJwk-unsplash.jpg)
A hydrogel delivery system boosts single-dose efficacy and provides a potential tool to fight future pandemics and vaccine inequity.
A rare group of patients have been found to maintain a very low viral load and a functional immune system after stopping antiviral treatment.
To create a flu vaccine that doesn’t require annual tweaking, researchers develop a nanovaccine that uses an inverted hemagglutinin protein.
A new hydrogel platform helps monitor chemotherapies in the body in real-time, allowing their side effects and potency to be better understood.
Red blood cells grown in a laboratory have now been transfused into another person in a world first clinical trial.
With the help of machine learning, a skin-like sensor internalizes different stimuli, allowing it to read and interpret hand movement.
Clumping proteins act as vaccine adjuvants, activating immune signalling pathways triggered by cell stress.
An RNA sequencing technique provides evidence for adult neurogenesis, the production of new neurons in the brain.
A fragile cancer immunotherapy agent “cGAMP” is delivered to tumor sites using tiny bubbles that protect it until it reaches its destination.
Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.